Percheron Therapeutics (ASX: PER)

Last close As at 02/09/2025

AUD0.01

0.00 (10.00%)

Market capitalisation

AUD10m

Percheron Therapeutics is an international biotechnology company focused on the development of novel therapies for oncology and rare diseases.

Latest Insights

Healthcare | edison tv

Percheron Therapeutics – executive interview

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Dr James Garner

    Managing Director & CEO

  • Ms Deborah Ambrosini

    CFO and Company Secretary

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free